Logo image of INLX

INTELLINETICS INC (INLX) Stock Fundamental Analysis

NYSEARCA:INLX - NYSE Arca - US45825X2045 - Common Stock - Currency: USD

13.9  -0.1 (-0.71%)

Fundamental Rating

3

Overall INLX gets a fundamental rating of 3 out of 10. We evaluated INLX against 282 industry peers in the Software industry. The financial health of INLX is average, but there are quite some concerns on its profitability. INLX does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

INLX had negative earnings in the past year.
INLX had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: INLX reported negative net income in multiple years.
In the past 5 years INLX always reported a positive cash flow from operatings.
INLX Yearly Net Income VS EBIT VS OCF VS FCFINLX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M

1.2 Ratios

INLX's Return On Assets of -6.12% is in line compared to the rest of the industry. INLX outperforms 46.10% of its industry peers.
INLX has a Return On Equity of -10.61%. This is comparable to the rest of the industry: INLX outperforms 51.06% of its industry peers.
Industry RankSector Rank
ROA -6.12%
ROE -10.61%
ROIC N/A
ROA(3y)-0.03%
ROA(5y)-2%
ROE(3y)0.16%
ROE(5y)-27.83%
ROIC(3y)N/A
ROIC(5y)N/A
INLX Yearly ROA, ROE, ROICINLX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200 -400 -600

1.3 Margins

With a Gross Margin value of 64.73%, INLX perfoms like the industry average, outperforming 44.68% of the companies in the same industry.
In the last couple of years the Gross Margin of INLX has declined.
The Profit Margin and Operating Margin are not available for INLX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 64.73%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.83%
GM growth 5Y-3.79%
INLX Yearly Profit, Operating, Gross MarginsINLX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100 -150

More info and screens

4

2. Health

2.1 Basic Checks

INLX does not have a ROIC to compare to the WACC, probably because it is not profitable.
INLX has more shares outstanding than it did 1 year ago.
INLX has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, INLX has an improved debt to assets ratio.
INLX Yearly Shares OutstandingINLX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M
INLX Yearly Total Debt VS Total AssetsINLX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

2.2 Solvency

INLX has an Altman-Z score of 3.76. This indicates that INLX is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of INLX (3.76) is better than 62.41% of its industry peers.
The Debt to FCF ratio of INLX is 0.70, which is an excellent value as it means it would take INLX, only 0.70 years of fcf income to pay off all of its debts.
INLX's Debt to FCF ratio of 0.70 is fine compared to the rest of the industry. INLX outperforms 75.89% of its industry peers.
INLX has a Debt/Equity ratio of 0.02. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.02, INLX is in the better half of the industry, outperforming 62.77% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF 0.7
Altman-Z 3.76
ROIC/WACCN/A
WACC10.94%
INLX Yearly LT Debt VS Equity VS FCFINLX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M

2.3 Liquidity

INLX has a Current Ratio of 0.79. This is a bad value and indicates that INLX is not financially healthy enough and could expect problems in meeting its short term obligations.
INLX has a Current ratio of 0.79. This is amonst the worse of the industry: INLX underperforms 81.21% of its industry peers.
INLX has a Quick Ratio of 0.79. This is a bad value and indicates that INLX is not financially healthy enough and could expect problems in meeting its short term obligations.
INLX has a Quick ratio of 0.78. This is amonst the worse of the industry: INLX underperforms 81.91% of its industry peers.
Industry RankSector Rank
Current Ratio 0.79
Quick Ratio 0.78
INLX Yearly Current Assets VS Current LiabilitesINLX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M

More info and screens

3

3. Growth

3.1 Past

INLX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -600.00%.
The Revenue has been growing slightly by 3.21% in the past year.
The Revenue has been growing by 48.02% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-600%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-325%
Revenue 1Y (TTM)3.21%
Revenue growth 3Y16.28%
Revenue growth 5Y48.02%
Sales Q2Q%-5.77%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-223%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year5.95%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
INLX Yearly Revenue VS EstimatesINLX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M
INLX Yearly EPS VS EstimatesINLX Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2020 2021 2022 2023 2024 2025 0 -2 -4 -6

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for INLX. In the last year negative earnings were reported.
Also next year INLX is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
INLX Price Earnings VS Forward Price EarningsINLX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 -40 60

4.2 Price Multiples

INLX's Enterprise Value to EBITDA ratio is in line with the industry average.
Based on the Price/Free Cash Flow ratio, INLX is valued a bit cheaper than the industry average as 75.18% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 27.08
EV/EBITDA 171.34
INLX Per share dataINLX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

INLX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

INTELLINETICS INC

NYSEARCA:INLX (7/18/2025, 8:04:01 PM)

13.9

-0.1 (-0.71%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)05-13 2025-05-13/amc
Earnings (Next)08-11 2025-08-11/amc
Inst Owners4.38%
Inst Owner Change0%
Ins Owners26.31%
Ins Owner Change0.92%
Market Cap59.91M
Analysts82.86
Price Target16.83 (21.08%)
Short Float %0.27%
Short Ratio0.87
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.28%
Min EPS beat(2)-85.19%
Max EPS beat(2)87.75%
EPS beat(4)1
Avg EPS beat(4)-257.69%
Min EPS beat(4)-982.35%
Max EPS beat(4)87.75%
EPS beat(8)2
Avg EPS beat(8)-160.46%
EPS beat(12)6
Avg EPS beat(12)-30.67%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-3.31%
Min Revenue beat(2)-6.54%
Max Revenue beat(2)-0.09%
Revenue beat(4)0
Avg Revenue beat(4)-2.97%
Min Revenue beat(4)-6.54%
Max Revenue beat(4)-0.09%
Revenue beat(8)2
Avg Revenue beat(8)-1.35%
Revenue beat(12)6
Avg Revenue beat(12)0.34%
Revenue beat(16)9
Avg Revenue beat(16)0.96%
PT rev (1m)-5.71%
PT rev (3m)-13.16%
EPS NQ rev (1m)-45.45%
EPS NQ rev (3m)-45.45%
EPS NY rev (1m)0%
EPS NY rev (3m)-216.67%
Revenue NQ rev (1m)-10.89%
Revenue NQ rev (3m)-10.89%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.5%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.37
P/FCF 27.08
P/OCF 19.1
P/B 5.78
P/tB 95.55
EV/EBITDA 171.34
EPS(TTM)-0.25
EYN/A
EPS(NY)-0.39
Fwd EYN/A
FCF(TTM)0.51
FCFY3.69%
OCF(TTM)0.73
OCFY5.23%
SpS4.12
BVpS2.4
TBVpS0.15
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -6.12%
ROE -10.61%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 64.73%
FCFM 12.46%
ROA(3y)-0.03%
ROA(5y)-2%
ROE(3y)0.16%
ROE(5y)-27.83%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.83%
GM growth 5Y-3.79%
F-Score5
Asset Turnover0.99
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF 0.7
Debt/EBITDA 0.47
Cap/Depr 78.8%
Cap/Sales 5.2%
Interest Coverage N/A
Cash Conversion 899.34%
Profit Quality N/A
Current Ratio 0.79
Quick Ratio 0.78
Altman-Z 3.76
F-Score5
WACC10.94%
ROIC/WACCN/A
Cap/Depr(3y)68.82%
Cap/Depr(5y)75.01%
Cap/Sales(3y)3.99%
Cap/Sales(5y)3.61%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-600%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-325%
EPS Next Y-223%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)3.21%
Revenue growth 3Y16.28%
Revenue growth 5Y48.02%
Sales Q2Q%-5.77%
Revenue Next Year5.95%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-204.38%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year651.12%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y224.19%
FCF growth 3Y55.92%
FCF growth 5YN/A
OCF growth 1Y134.35%
OCF growth 3Y40.54%
OCF growth 5YN/A